The study reported that Oatp2a1 is likely to promote tumorogenesis by PGE2 uptake into the endothelial cells; blockade of Oatp2a1 is an additional pharmacologic strategy to improve colon cancer outcomes [20]. The gene discussed is SLCO2A1; the disease is malignant colon neoplasm.